secwatch.observer — SEC 8-K summary
======================================

Issuer:     Edgewise Therapeutics, Inc. (EWTX)
CIK:        0001710072
Form:       8-K
Filed at:   2022-09-14T23:59:59+00:00
Accession:  0001104659-22-100078
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Edgewise Therapeutics announces public offering of 11.6M shares at $10.32/share, expected gross proceeds $120M
--------------------------------------------------------------------------------

- Underwritten 11,627,907 shares; underwriters have 30-day option for additional 1,744,186 shares.
- Public offering price $10.32/share; underwriters purchase at $9.70/share.
- Expected gross proceeds of $120M before offering expenses; closing expected September 16, 2022.
- Offering made via effective S-3 registration statement (333-264083); J.P. Morgan and SVB Securities as representatives.
- Underwriting agreement includes customary representations, warranties, and indemnification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1710072/000110465922100078/0001104659-22-100078-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1710072/000110465922100078/tm2221772d4_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-100078

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer